Bellevue Life Sciences Acquisition (BLAC) Institutional Ownership $2.40 -0.59 (-19.73%) As of 03/28/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Bellevue Life Sciences Acquisition (NASDAQ:BLAC)CurrentInstitutional OwnershipPercentage55.30%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$5.54MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$4.91M Get BLAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Bellevue Life Sciences Acquisition stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLAC Institutional Buying and Selling by Quarter Remove Ads Bellevue Life Sciences Acquisition Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Berkley W R Corp173,901$1.89M0.1%+75.0%4.304% 11/4/2024 Wolverine Asset Management LLC267,072$2.91M0.0%-0.7%6.611% 8/16/2024 Quarry LP65,000$701K0.2%N/A1.156% 8/14/2024 Berkley W R Corp99,358$1.07M0.0%-69.2%1.767% 8/12/2024 Clear Street LLC8,592$92K0.0%+6,942.6%0.153% 8/9/2024 Warberg Asset Management LLC39,781$429K0.1%+47.1%0.707% 8/7/2024 Cowen AND Company LLC193,376$2.08M0.1%-47.7%3.439% 8/2/2024 Wolverine Asset Management LLC268,878$2.89M0.0%-7.8%4.784% 5/16/2024 Berkley W R Corp322,690$3.44M0.2%N/A5.742% 5/14/2024 K2 Principal Fund L.P.33,589$358K0.1%N/A0.598% Get the Latest News and Ratings for BLAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. 4/18/2024 Wealthspring Capital LLC54,895$585K0.7%-37.3%0.606% 2/13/2024 Karpus Management Inc.86,650$910K0.0%-16.1%0.956% 2/12/2024 Condor Capital Management11,570$121K0.0%N/A0.128% 2/8/2024 Mizuho Securities USA LLC133,495$1.39M0.0%N/A1.473% 2/8/2024 Cowen AND Company LLC15,750$165K0.0%N/A0.174% 2/1/2024 Wolverine Asset Management LLC183,110$1.92M0.0%+5.8%2.021% 1/17/2024 Schechter Investment Advisors LLC211,227$2.22M0.2%+84.1%2.331% 1/16/2024 Wealthspring Capital LLC87,579$920K1.2%+335.7%0.967% 11/14/2023 AQR Arbitrage LLC449,702$4.68M0.2%+349.7%4.966% 11/14/2023 Robinson Capital Management LLC42,000$438K0.2%N/A0.464% 11/13/2023 Wolverine Asset Management LLC173,110$1.80M0.0%+40.6%1.911% 11/9/2023 Commonwealth of Pennsylvania Public School Empls Retrmt SYS220,723$2.30M0.0%+82.8%2.438% 11/6/2023 Schechter Investment Advisors LLC114,711$1.19M0.1%+277.2%1.267% 11/6/2023 Periscope Capital Inc.615,652$6.40M0.7%+2,175.8%6.799% 10/23/2023 Deltec Asset Management LLC106,248$1.11M0.3%N/A1.173% 10/23/2023 Spartan Fund Management Inc.174,300$1.81M1.4%-12.9%1.924% 10/20/2023 Wealthspring Capital LLC20,100$209K0.4%N/A0.222% 8/15/2023 Bulldog Investors LLP21,620$222K0.1%-8.6%0.239% 8/14/2023 Aristeia Capital LLC165,000$1.69M0.0%+120.0%1.821% 8/14/2023 DLD Asset Management LP70,421$723K0.1%N/A0.777% 8/14/2023 Kim LLC227,693$2.34M0.2%+66.2%2.513% 8/14/2023 Radcliffe Capital Management L.P.150,000$1.54M0.1%N/A1.656% 8/11/2023 Karpus Management Inc.103,250$1.06M0.0%+4.0%1.140% 8/10/2023 Gabelli Funds LLC29,200$300K0.0%N/A0.322% 8/10/2023 GABELLI & Co INVESTMENT ADVISERS INC.20,800$213K0.0%N/A0.230% 8/9/2023 Commonwealth of Pennsylvania Public School Empls Retrmt SYS120,723$1.24M0.0%N/A1.332% 8/7/2023 Wolverine Asset Management LLC123,110$1.26M0.0%+1.3%1.359% 7/31/2023 Spartan Fund Management Inc.200,000$2.05M1.0%N/A2.208% 7/26/2023 Spartan Fund Management Inc.57,173$2.05M1.0%N/A0.631% 5/24/2023 Mint Tower Capital Management B.V.75,000$758K0.0%N/A0.828% New “Trump” currency proposed in DC (Ad)According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. When you see what could happen – I think you’ll be excited.5/12/2023 Periscope Capital Inc.27,052$273K0.0%N/A0.299% 5/12/2023 Clear Street LLC115,264$1.16M0.0%N/A1.273% 5/11/2023 Karpus Management Inc.99,250$1.00M0.0%N/A1.096% 5/11/2023 Kim LLC137,000$1.38M0.1%N/A1.513% 5/10/2023 Mint Tower Capital Management B.V.225,000$777K0.1%N/A2.483% 5/9/2023 Cowen AND Company LLC63,300$639K0.1%N/A0.699% 5/9/2023 Mint Tower Capital Management B.V.225,000$1.53M0.1%N/A2.483% 5/8/2023 Wolverine Asset Management LLC121,585$1.23M0.0%N/A1.342% 5/5/2023Gritstone Asset Management LLC155,037$1.57M2.0%N/A1.711% (Data available from 1/1/2016 forward)Remove Ads BLAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLAC shares? During the previous two years, 27 institutional investors and hedge funds held shares of Bellevue Life Sciences Acquisition. The most heavily invested institutionals were Periscope Capital Inc. ($6.40M), AQR Arbitrage LLC ($4.68M), Wolverine Asset Management LLC ($2.91M), Kim LLC ($2.34M), Commonwealth of Pennsylvania Public School Empls Retrmt SYS ($2.30M), Schechter Investment Advisors LLC ($2.22M), and Cowen AND Company LLC ($2.08M).Learn more on BLAC's institutional investors. What percentage of Bellevue Life Sciences Acquisition stock is owned by institutional investors? 55.30% of Bellevue Life Sciences Acquisition stock is owned by institutional investors. Learn more on BLAC's institutional investor holdings. Which institutional investors have been buying Bellevue Life Sciences Acquisition stock? Of the 26 institutional investors that purchased Bellevue Life Sciences Acquisition stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Periscope Capital Inc. ($615.65K), Mint Tower Capital Management B.V. ($525K), Berkley W R Corp ($397.23K), AQR Arbitrage LLC ($349.70K), Spartan Fund Management Inc. ($257.17K), Kim LLC ($227.69K), and Commonwealth of Pennsylvania Public School Empls Retrmt SYS ($220.72K). How much institutional buying is happening at Bellevue Life Sciences Acquisition? Institutional investors have bought a total of 4,270,816 shares in the last 24 months. This purchase volume represents approximately $44.12M in transactions. Which Bellevue Life Sciences Acquisition major shareholders have been selling company stock? The following institutional investors have sold Bellevue Life Sciences Acquisition stock in the last 24 months: Berkley W R Corp ($223.33K), Cowen AND Company LLC ($176.48K), Wealthspring Capital LLC ($32.68K), Spartan Fund Management Inc. ($25.70K), Wolverine Asset Management LLC ($24.43K), Karpus Management Inc. ($16.60K), and Bulldog Investors LLP ($2.04K). How much institutional selling is happening at Bellevue Life Sciences Acquisition? Institutional investors have sold a total of 501,269 shares in the last 24 months. This volume of shares sold represents approximately $5.38M in transactions. Related Companies DRIO Institutional Ownership SURG Institutional Ownership MDAI Institutional Ownership RVP Institutional Ownership NXGL Institutional Ownership XAIR Institutional Ownership VVOS Institutional Ownership LFWD Institutional Ownership NEPH Institutional Ownership ALUR Institutional Ownership This page (NASDAQ:BLAC) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
